Review



recombinant wnt11 protein  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    R&D Systems recombinant wnt11 protein
    a Relative mRNA level of <t>WNT11</t> in fibrotic bladders following BPNI and SCI ( n = 8). Western blotting of WNT11 expression in BPNI ( b ) and SCI ( c )-induced NB. Representative photomicrographs showed that WNT11 (green) was increased in rats after BPNI ( d ) and SCI ( e ). Scale bar = 400 μm. Protein levels of fibroblasts differentiation-related markers (α-SMA and Col-1) in BFs isolated from rats treated with BPNI ( f ) and SCI ( g ). Representative western blotting showing the phenotypic transformation of SMCs (SMTN and MYH10) in BPNI ( h ) and SCI ( i ) rats. Western blotting analyses showing protein levels of WNT11 and markers of fibroblastic differentiation (α-SMA and Col-1) and SMCs phenotypic transformation (SMTN and MYH10) in BFs ( j ) and SMCs ( k ) treated with TGF-β1 at different doses, respectively. Data are shown as the mean ± SD, and P values were determined by the one-way ANOVA followed by Tukey’s post-hoc test ( a ), * P < 0.05, ** P < 0.01.
    Recombinant Wnt11 Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 23 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+wnt11/Recombinant+Human+Wnt-11+Protein/pmc12886777-234-14-18
    Average 94 stars, based on 23 article reviews
    recombinant wnt11 protein - by Bioz Stars, 2026-11
    94/100 stars

    Images

    1) Product Images from "Wnt11 mediates fibroblast–smooth muscle cell interaction to promote neurogenic bladder fibrosis in rats"

    Article Title: Wnt11 mediates fibroblast–smooth muscle cell interaction to promote neurogenic bladder fibrosis in rats

    Journal: Communications Biology

    doi: 10.1038/s42003-026-09647-2

    a Relative mRNA level of WNT11 in fibrotic bladders following BPNI and SCI ( n = 8). Western blotting of WNT11 expression in BPNI ( b ) and SCI ( c )-induced NB. Representative photomicrographs showed that WNT11 (green) was increased in rats after BPNI ( d ) and SCI ( e ). Scale bar = 400 μm. Protein levels of fibroblasts differentiation-related markers (α-SMA and Col-1) in BFs isolated from rats treated with BPNI ( f ) and SCI ( g ). Representative western blotting showing the phenotypic transformation of SMCs (SMTN and MYH10) in BPNI ( h ) and SCI ( i ) rats. Western blotting analyses showing protein levels of WNT11 and markers of fibroblastic differentiation (α-SMA and Col-1) and SMCs phenotypic transformation (SMTN and MYH10) in BFs ( j ) and SMCs ( k ) treated with TGF-β1 at different doses, respectively. Data are shown as the mean ± SD, and P values were determined by the one-way ANOVA followed by Tukey’s post-hoc test ( a ), * P < 0.05, ** P < 0.01.
    Figure Legend Snippet: a Relative mRNA level of WNT11 in fibrotic bladders following BPNI and SCI ( n = 8). Western blotting of WNT11 expression in BPNI ( b ) and SCI ( c )-induced NB. Representative photomicrographs showed that WNT11 (green) was increased in rats after BPNI ( d ) and SCI ( e ). Scale bar = 400 μm. Protein levels of fibroblasts differentiation-related markers (α-SMA and Col-1) in BFs isolated from rats treated with BPNI ( f ) and SCI ( g ). Representative western blotting showing the phenotypic transformation of SMCs (SMTN and MYH10) in BPNI ( h ) and SCI ( i ) rats. Western blotting analyses showing protein levels of WNT11 and markers of fibroblastic differentiation (α-SMA and Col-1) and SMCs phenotypic transformation (SMTN and MYH10) in BFs ( j ) and SMCs ( k ) treated with TGF-β1 at different doses, respectively. Data are shown as the mean ± SD, and P values were determined by the one-way ANOVA followed by Tukey’s post-hoc test ( a ), * P < 0.05, ** P < 0.01.

    Techniques Used: Western Blot, Expressing, Isolation, Transformation Assay

    a – n Eight-week-old male Sprague–Dawley rats were subjected to sham, BPNI, or SCI operation. Vehicle, WNT11, or LGK974 were administered to rats every day after the surgical procedure for 2 weeks, and these rats were euthanized at post 4 weeks of operation. a Schematic of the experimental protocol and treatment regimen. b Representative bladder images in rats treated with vehicle, WNT11, or LGK974 post BPNI or SCI. Representative images of cystometrograms in rats after BPNI ( c ) or SCI ( d ). Statistical results for the intravesical pressure in rats after BPNI ( e ) or SCI ( f ) ( n = 5). Histological analysis of the Masson’s trichrome staining in bladders after BPNI ( g ) or SCI ( h ). Scale bar = 200 μm. Quantifications of detrusor thickness ( i , j ) and collagen content ( k , l ) by Masson’s trichrome staining were performed to assess the bladder fibrosis ( n = 5). Western blotting showing the protein levels of WNT11 and markers of fibroblastic differentiation (α-SMA and Col-1) and SMCs phenotypic transformation (SMTN and MYH10) in bladders after BPNI ( m ) or SCI ( n ). Western blotting analyses showing protein levels of TGF-β1 and markers of fibroblastic differentiation (α-SMA and Col-1) and SMCs phenotypic transformation (SMTN and MYH10) in BFs ( o ) and SMCs ( p ) treated with WNT11 at different doses. Western blotting analyses showing siWNT11 transfection inhibiting fibroblastic differentiation and SMCs phenotypic transformation in BFs ( q ) and SMCs ( r ) with TGF-β1 treatment, respectively. Data are shown as the mean ± SD, and P values were determined by the two-way ANOVA followed by Tukey’s post-hoc test ( e , f , i – l ), ns = not significant, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
    Figure Legend Snippet: a – n Eight-week-old male Sprague–Dawley rats were subjected to sham, BPNI, or SCI operation. Vehicle, WNT11, or LGK974 were administered to rats every day after the surgical procedure for 2 weeks, and these rats were euthanized at post 4 weeks of operation. a Schematic of the experimental protocol and treatment regimen. b Representative bladder images in rats treated with vehicle, WNT11, or LGK974 post BPNI or SCI. Representative images of cystometrograms in rats after BPNI ( c ) or SCI ( d ). Statistical results for the intravesical pressure in rats after BPNI ( e ) or SCI ( f ) ( n = 5). Histological analysis of the Masson’s trichrome staining in bladders after BPNI ( g ) or SCI ( h ). Scale bar = 200 μm. Quantifications of detrusor thickness ( i , j ) and collagen content ( k , l ) by Masson’s trichrome staining were performed to assess the bladder fibrosis ( n = 5). Western blotting showing the protein levels of WNT11 and markers of fibroblastic differentiation (α-SMA and Col-1) and SMCs phenotypic transformation (SMTN and MYH10) in bladders after BPNI ( m ) or SCI ( n ). Western blotting analyses showing protein levels of TGF-β1 and markers of fibroblastic differentiation (α-SMA and Col-1) and SMCs phenotypic transformation (SMTN and MYH10) in BFs ( o ) and SMCs ( p ) treated with WNT11 at different doses. Western blotting analyses showing siWNT11 transfection inhibiting fibroblastic differentiation and SMCs phenotypic transformation in BFs ( q ) and SMCs ( r ) with TGF-β1 treatment, respectively. Data are shown as the mean ± SD, and P values were determined by the two-way ANOVA followed by Tukey’s post-hoc test ( e , f , i – l ), ns = not significant, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

    Techniques Used: Staining, Western Blot, Transformation Assay, Transfection

    Representative western blotting and quantitative analyses for FZD10 and Vangl2 in bladders after BPNI ( a ) or SCI ( b ) ( n = 6). Interaction between endogenous WNT11 and Vangl2 in BFs ( c ) and SMCs ( d ). e Confocal microscopy analysis of BFs and SMCs showing the colocalization of WNT11 (red) and Vangl2 (green). Scale bar = 20 μm. Quantification of colocalization was ascertained by ImageJ software in five randomly chosen fields. Numbers in the images correspond to the average Pearson’s correlation coefficient ± SD. Representative Western blotting and summarized data showing the relative protein levels of Vangl2 and markers of fibroblastic differentiation (α-SMA and Col-1) and SMCs phenotypic transformation (SMTN and MYH10) in BFs ( f ) and SMCs ( g ) ( n = 4). Data are shown as the mean ± SD. P values were determined by the two-tailed unpaired Student’s t -test ( a , b ) and the two-way ANOVA followed by Tukey’s post-hoc test ( f , g ), * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
    Figure Legend Snippet: Representative western blotting and quantitative analyses for FZD10 and Vangl2 in bladders after BPNI ( a ) or SCI ( b ) ( n = 6). Interaction between endogenous WNT11 and Vangl2 in BFs ( c ) and SMCs ( d ). e Confocal microscopy analysis of BFs and SMCs showing the colocalization of WNT11 (red) and Vangl2 (green). Scale bar = 20 μm. Quantification of colocalization was ascertained by ImageJ software in five randomly chosen fields. Numbers in the images correspond to the average Pearson’s correlation coefficient ± SD. Representative Western blotting and summarized data showing the relative protein levels of Vangl2 and markers of fibroblastic differentiation (α-SMA and Col-1) and SMCs phenotypic transformation (SMTN and MYH10) in BFs ( f ) and SMCs ( g ) ( n = 4). Data are shown as the mean ± SD. P values were determined by the two-tailed unpaired Student’s t -test ( a , b ) and the two-way ANOVA followed by Tukey’s post-hoc test ( f , g ), * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

    Techniques Used: Western Blot, Confocal Microscopy, Software, Transformation Assay, Two Tailed Test

    Representative western blotting and quantitative analyses for the phosphorylation levels of JNK and c-JUN in bladders after BPNI ( a ) or SCI ( b ) ( n = 3). BFs ( c ) and SMCs ( d ) developed higher expression levels of p-JNK and p-c-JUN upon WNT11 treatment as indicated by the western blotting and quantitative analyses ( n = 4). Representative immunofluorescence staining and quantitative analyses showing that WNT11 treatment increased the fluorescence intensity and accumulation of p-c-JUN in the nucleus of BFs ( e ) and SMCs ( f ) ( n = 4). Scale bar=100μm. Protein levels of p-JNK, p-c-JUN, and markers of fibroblastic differentiation (α-SMA and Col-1) and SMCs phenotypic transformation (SMTN and MYH10) in BFs ( g ) and SMCs ( h ) treated with WNT11 with or without SP600125 by western blotting ( n = 3). Data are shown as the mean ± SD. P values were determined by the two-way ANOVA followed by Tukey’s post-hoc test ( a , b , g , h ) and the two-tailed unpaired student’s t -test ( c – f ), * P < 0.05, ** P < 0.01, *** P < 0.001.
    Figure Legend Snippet: Representative western blotting and quantitative analyses for the phosphorylation levels of JNK and c-JUN in bladders after BPNI ( a ) or SCI ( b ) ( n = 3). BFs ( c ) and SMCs ( d ) developed higher expression levels of p-JNK and p-c-JUN upon WNT11 treatment as indicated by the western blotting and quantitative analyses ( n = 4). Representative immunofluorescence staining and quantitative analyses showing that WNT11 treatment increased the fluorescence intensity and accumulation of p-c-JUN in the nucleus of BFs ( e ) and SMCs ( f ) ( n = 4). Scale bar=100μm. Protein levels of p-JNK, p-c-JUN, and markers of fibroblastic differentiation (α-SMA and Col-1) and SMCs phenotypic transformation (SMTN and MYH10) in BFs ( g ) and SMCs ( h ) treated with WNT11 with or without SP600125 by western blotting ( n = 3). Data are shown as the mean ± SD. P values were determined by the two-way ANOVA followed by Tukey’s post-hoc test ( a , b , g , h ) and the two-tailed unpaired student’s t -test ( c – f ), * P < 0.05, ** P < 0.01, *** P < 0.001.

    Techniques Used: Western Blot, Phospho-proteomics, Expressing, Immunofluorescence, Staining, Fluorescence, Transformation Assay, Two Tailed Test

    Relative mRNA levels of DVL1, DVL2, and DVL3 in fibrotic bladders at 4 weeks after BPNI ( a ) and SCI ( b ) ( n = 6). Representative western blotting and quantitative analyses for the protein levels of DVL1, DVL2, and DVL3 in bladders after BPNI ( c ) or SCI ( d ) ( n = 6). e Representative western blotting and quantitative analyses revealing the protein levels of DVL2 and markers of fibroblastic differentiation, and the phosphorylation levels of JNK and c-JUN in BFs ( n = 3). f Protein levels of p-c-JUN, p-JNK, DVL2, SMTN, and MYH10 in SMCs treated with WNT11 and/or siDVL2 ( n = 3). Immunoprecipitation demonstrated that DVL2 bound to Vangl2 in BFs ( g ) and SMCs ( h ). Representative western blotting showing the presence of the target proteins (input) and immunoprecipitation showing the interaction of Flag-DVL2, Flag-DEP, Flag-DIX, and Flag-PDZ with endogenous Vangl2 in HEK293T cells using antibodies to Flag ( i ) and IgG ( j ). Data are shown as the mean ± SD. P values were determined by the two-tailed unpaired Student’s t -test ( a – d ) and the two-way ANOVA followed by Tukey’s post-hoc test ( e , f ), * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
    Figure Legend Snippet: Relative mRNA levels of DVL1, DVL2, and DVL3 in fibrotic bladders at 4 weeks after BPNI ( a ) and SCI ( b ) ( n = 6). Representative western blotting and quantitative analyses for the protein levels of DVL1, DVL2, and DVL3 in bladders after BPNI ( c ) or SCI ( d ) ( n = 6). e Representative western blotting and quantitative analyses revealing the protein levels of DVL2 and markers of fibroblastic differentiation, and the phosphorylation levels of JNK and c-JUN in BFs ( n = 3). f Protein levels of p-c-JUN, p-JNK, DVL2, SMTN, and MYH10 in SMCs treated with WNT11 and/or siDVL2 ( n = 3). Immunoprecipitation demonstrated that DVL2 bound to Vangl2 in BFs ( g ) and SMCs ( h ). Representative western blotting showing the presence of the target proteins (input) and immunoprecipitation showing the interaction of Flag-DVL2, Flag-DEP, Flag-DIX, and Flag-PDZ with endogenous Vangl2 in HEK293T cells using antibodies to Flag ( i ) and IgG ( j ). Data are shown as the mean ± SD. P values were determined by the two-tailed unpaired Student’s t -test ( a – d ) and the two-way ANOVA followed by Tukey’s post-hoc test ( e , f ), * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

    Techniques Used: Western Blot, Phospho-proteomics, Immunoprecipitation, Two Tailed Test

    Under the condition of bladder denervation, the WNT11/Vangl2 signal was transmitted into the cytoplasm via DVL2, followed by activating PCP signaling to promote fibroblastic differentiation and SMC phenotypic transformation, which also depended on the interaction of TGF-β1/Smad2/3 signaling at the level of cytomembrane and nucleus, eventually resulting in NB fibrosis.
    Figure Legend Snippet: Under the condition of bladder denervation, the WNT11/Vangl2 signal was transmitted into the cytoplasm via DVL2, followed by activating PCP signaling to promote fibroblastic differentiation and SMC phenotypic transformation, which also depended on the interaction of TGF-β1/Smad2/3 signaling at the level of cytomembrane and nucleus, eventually resulting in NB fibrosis.

    Techniques Used: Transformation Assay

    Related Articles

    Recombinant:

    Article Title: WNT5a is required for normal ovarian follicle development and antagonizes gonadotropin responsiveness in granulosa cells by suppressing canonical WNT signaling
    Article Snippet: .. Culture medium was then replaced with serum-free medium for 2 h before addition of recombinant WNT11 or -5a (R&D Systems, Minneapolis, MN, USA). .. For some experiments, small-molecule inhibitors (Tocris Bioscience, Bristol, United Kingdom) were added to the culture medium 1 h before addition of WNT5a.

    Article Title: WNT regulation of embryonic development likely involves pathways independent of nuclear CTNNB1
    Article Snippet: .. In each culture drop, 5 μL of SOF-BE2 were replaced by either 5 μL human 298 Page 14 of 46 15 recombinant WNT11 (R&D systems, Minneapolis, MN, USA; 98% amino acid sequence 299 identity with bovine WNT11) or 5 μL vehicle [SOF-BE2 containing 0.01 % (w/v) BSA (in 300 addition to BSA included in SOF-BE2 formulation)]. ..

    Article Title: Transcriptome Complexity of Neonatal Heart during Perinatal Circulatory Transition: -- a Road Map for Functional Discovery
    Article Snippet: .. On next day, cells were incubated with 200 ng/ml recombinant Wnt11 (R&D Systems) for 48 h. For Wnt11 siRNA treatment, NRVMs were transfected in 6-well plates with 30 nM siRNA and 6 μL Lipofectamine® RNAiMAX Transfection Reagent (Life Technologies) in Opti-MEM (Life Technologies). .. Culture medium was changed to DMEM/5% FBS after 4 h. After 48 h, total RNA was obtained using TRIzol reagent (LifeTechnologies) and total protein was isolated using cell lysis buffer.

    Article Title: Wnt11 in regulation of physiological and pathological cardiac growth
    Article Snippet: The experiments were started 2 days after isolation in complete serum- free medium (CSFM) containing 2.5 mg/ml bovine serum albumin (BSA) (Sigma), 5 μg/ml– 5 μg/ml– 5 ng/ml insulin– transferrin– sodium selenite (ITS) (Roche, Basel, Switzerland), 2.8 mM Napyruvate, 0.1 nM T3 (Sigma), and 1% PS in DMEM/F12. .. Recombinant Wnt11 and Wnt5a proteins (R&D Systems, Minneapolis, MN, USA) were added as 200 ng/ ml. ..

    Article Title: Wnt11 mediates fibroblast-smooth muscle cell interaction to promote neurogenic bladder fibrosis in rats.
    Article Snippet: .. For induction of BFs differentiation and SMCs phenotypic transition, cells were seeded on six-well culture plates to 80% confluence in complete DMEM/F12 supplemented with 10% FBS and subjected to serum starved in serum-free medium for 24 h, and then stimulated with 2.5, 5, 10, 20 ng/ml of recombinant TGF-β1 (#CK33, Communications Biology | (2026) 9:194 13 Novoprotein) or 25, 50, 100, 200 ng/ml of recombinant WNT11(#6179WN-010, R&D Systems) for 12 h or 24 h, respectively. ..

    Article Title: Method for differentiation into retinal cells from stem cells
    Article Snippet: .. Differentiation from retinal progenitor cells into neural retinal progenitor cells, from neural retinal progenitor cells into photoreceptor cell precursors, and from photoreceptor cells into photoreceptor cells was induced in the same manner as in Examples 4 to 6, with the exception that the media used in Examples 4 to 6 contained 50 ng/ml recombinant Wnt1 (PeproTech, Rocky Hill, N.J., USA), 50 and 100 ng/ml recombinant Wnt5A (R&D Systems), 50 and 100 ng/ml recombinant Wnt11 (R&D Systems), 50 ng/ml recombinant Norrin (R&D Systems), 2.5 and 5 mM LiCl (Sigma-Aldrich), 2 μM BIO (Sigma-Aldrich), or 30 μM SB415286 (Sigma-Aldrich), instead of the recombinant Wnt3a, and with the further exception that the media used in Examples 5 and 6 contained 1 μM purmorphamine (Stemgent, Cambridge, Mass., USA) instead of the recombinant Shh. ..

    Sequencing:

    Article Title: WNT regulation of embryonic development likely involves pathways independent of nuclear CTNNB1
    Article Snippet: .. In each culture drop, 5 μL of SOF-BE2 were replaced by either 5 μL human 298 Page 14 of 46 15 recombinant WNT11 (R&D systems, Minneapolis, MN, USA; 98% amino acid sequence 299 identity with bovine WNT11) or 5 μL vehicle [SOF-BE2 containing 0.01 % (w/v) BSA (in 300 addition to BSA included in SOF-BE2 formulation)]. ..

    Formulation:

    Article Title: WNT regulation of embryonic development likely involves pathways independent of nuclear CTNNB1
    Article Snippet: .. In each culture drop, 5 μL of SOF-BE2 were replaced by either 5 μL human 298 Page 14 of 46 15 recombinant WNT11 (R&D systems, Minneapolis, MN, USA; 98% amino acid sequence 299 identity with bovine WNT11) or 5 μL vehicle [SOF-BE2 containing 0.01 % (w/v) BSA (in 300 addition to BSA included in SOF-BE2 formulation)]. ..

    Incubation:

    Article Title: Transcriptome Complexity of Neonatal Heart during Perinatal Circulatory Transition: -- a Road Map for Functional Discovery
    Article Snippet: .. On next day, cells were incubated with 200 ng/ml recombinant Wnt11 (R&D Systems) for 48 h. For Wnt11 siRNA treatment, NRVMs were transfected in 6-well plates with 30 nM siRNA and 6 μL Lipofectamine® RNAiMAX Transfection Reagent (Life Technologies) in Opti-MEM (Life Technologies). .. Culture medium was changed to DMEM/5% FBS after 4 h. After 48 h, total RNA was obtained using TRIzol reagent (LifeTechnologies) and total protein was isolated using cell lysis buffer.

    Transfection:

    Article Title: Transcriptome Complexity of Neonatal Heart during Perinatal Circulatory Transition: -- a Road Map for Functional Discovery
    Article Snippet: .. On next day, cells were incubated with 200 ng/ml recombinant Wnt11 (R&D Systems) for 48 h. For Wnt11 siRNA treatment, NRVMs were transfected in 6-well plates with 30 nM siRNA and 6 μL Lipofectamine® RNAiMAX Transfection Reagent (Life Technologies) in Opti-MEM (Life Technologies). .. Culture medium was changed to DMEM/5% FBS after 4 h. After 48 h, total RNA was obtained using TRIzol reagent (LifeTechnologies) and total protein was isolated using cell lysis buffer.



    Similar Products

    94
    Bio-Techne corporation recombinant human wnt-11 protein
    Recombinant Human Wnt 11 Protein, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+wnt11/Recombinant+Human+Wnt-11+Protein/bio-techne+corporation___6179-wn
    Average 94 stars, based on 1 article reviews
    recombinant human wnt-11 protein - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    93
    OriGene recombinant wnt11 protein
    Recombinant Wnt11 Protein, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+wnt11/WNT11+(NM_004626)+Human+Recombinant+Protein/pm42907595-59-47-50
    Average 93 stars, based on 1 article reviews
    recombinant wnt11 protein - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    94
    R&D Systems recombinant wnt11 protein
    a Relative mRNA level of <t>WNT11</t> in fibrotic bladders following BPNI and SCI ( n = 8). Western blotting of WNT11 expression in BPNI ( b ) and SCI ( c )-induced NB. Representative photomicrographs showed that WNT11 (green) was increased in rats after BPNI ( d ) and SCI ( e ). Scale bar = 400 μm. Protein levels of fibroblasts differentiation-related markers (α-SMA and Col-1) in BFs isolated from rats treated with BPNI ( f ) and SCI ( g ). Representative western blotting showing the phenotypic transformation of SMCs (SMTN and MYH10) in BPNI ( h ) and SCI ( i ) rats. Western blotting analyses showing protein levels of WNT11 and markers of fibroblastic differentiation (α-SMA and Col-1) and SMCs phenotypic transformation (SMTN and MYH10) in BFs ( j ) and SMCs ( k ) treated with TGF-β1 at different doses, respectively. Data are shown as the mean ± SD, and P values were determined by the one-way ANOVA followed by Tukey’s post-hoc test ( a ), * P < 0.05, ** P < 0.01.
    Recombinant Wnt11 Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+wnt11/Recombinant+Human+Wnt-11+Protein/pmc12886777-234-14-18
    Average 94 stars, based on 1 article reviews
    recombinant wnt11 protein - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    R&D Systems recombinant wnt11
    a Relative mRNA level of <t>WNT11</t> in fibrotic bladders following BPNI and SCI ( n = 8). Western blotting of WNT11 expression in BPNI ( b ) and SCI ( c )-induced NB. Representative photomicrographs showed that WNT11 (green) was increased in rats after BPNI ( d ) and SCI ( e ). Scale bar = 400 μm. Protein levels of fibroblasts differentiation-related markers (α-SMA and Col-1) in BFs isolated from rats treated with BPNI ( f ) and SCI ( g ). Representative western blotting showing the phenotypic transformation of SMCs (SMTN and MYH10) in BPNI ( h ) and SCI ( i ) rats. Western blotting analyses showing protein levels of WNT11 and markers of fibroblastic differentiation (α-SMA and Col-1) and SMCs phenotypic transformation (SMTN and MYH10) in BFs ( j ) and SMCs ( k ) treated with TGF-β1 at different doses, respectively. Data are shown as the mean ± SD, and P values were determined by the one-way ANOVA followed by Tukey’s post-hoc test ( a ), * P < 0.05, ** P < 0.01.
    Recombinant Wnt11, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+wnt11/Recombinant+Human+Wnt-11+Protein/pm41663583-251-64-66
    Average 94 stars, based on 1 article reviews
    recombinant wnt11 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    93
    OriGene wnt11
    Isolation, characterization and differentiation of chicken enteric neurospheres. Schematic figure of avian enteric neurosphere generation (A) . Brightfield images show examples of neurospheres generated from E8 ENSCs that emerged 1, 3, and 7 days in GDNF-containing medium (B–D) . Representative immunofluorescence images of 7-day-old neurospheres generated from E8 chicken intestine (E–G) . Samples were cultured under three different conditions: Exp.1: control medium ( (E) , CTRL), Exp. 2: GDNF containing cell culture media ( (F) , GDNF), and Exp.3: GWEN ( (G) , ceca-derived mesenchymal growth factors: GDNF, <t>WNT11,</t> ET-3, Noggin) supplemented media. Immunofluorescence of cross-sections confirms the presence of neurons expressing TUJ1, and neural crest cells expressing PHOX2B. Compared to CTRL and GDNF-only conditions, GWEN treatment resulted in a robust increase in TUJ1+/PHOX2B+ cell aggregates on the surface of the neurosphere and single Phox2b+ cells in the center of the aggregates. The inset shows a magnified view of a PHOX2B+/TUJ1+ aggregate, indicating enhanced differentiation of neural crest derivatives (E–G) . Scale bar = 100 µm. CTRL, control; NS, neurosphere.
    Wnt11, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+wnt11/WNT11+(NM_004626)+Human+Recombinant+Protein/pmc12756466-63-33-34
    Average 93 stars, based on 1 article reviews
    wnt11 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    90
    Bio-Techne corporation recombinant human wnt-11 protein, cf
    Isolation, characterization and differentiation of chicken enteric neurospheres. Schematic figure of avian enteric neurosphere generation (A) . Brightfield images show examples of neurospheres generated from E8 ENSCs that emerged 1, 3, and 7 days in GDNF-containing medium (B–D) . Representative immunofluorescence images of 7-day-old neurospheres generated from E8 chicken intestine (E–G) . Samples were cultured under three different conditions: Exp.1: control medium ( (E) , CTRL), Exp. 2: GDNF containing cell culture media ( (F) , GDNF), and Exp.3: GWEN ( (G) , ceca-derived mesenchymal growth factors: GDNF, <t>WNT11,</t> ET-3, Noggin) supplemented media. Immunofluorescence of cross-sections confirms the presence of neurons expressing TUJ1, and neural crest cells expressing PHOX2B. Compared to CTRL and GDNF-only conditions, GWEN treatment resulted in a robust increase in TUJ1+/PHOX2B+ cell aggregates on the surface of the neurosphere and single Phox2b+ cells in the center of the aggregates. The inset shows a magnified view of a PHOX2B+/TUJ1+ aggregate, indicating enhanced differentiation of neural crest derivatives (E–G) . Scale bar = 100 µm. CTRL, control; NS, neurosphere.
    Recombinant Human Wnt 11 Protein, Cf, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+wnt11/Recombinant+Human+Wnt-11+Protein%2C+CF/bio-techne+corporation___6179-wn-cf
    Average 90 stars, based on 1 article reviews
    recombinant human wnt-11 protein, cf - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    Image Search Results


    a Relative mRNA level of WNT11 in fibrotic bladders following BPNI and SCI ( n = 8). Western blotting of WNT11 expression in BPNI ( b ) and SCI ( c )-induced NB. Representative photomicrographs showed that WNT11 (green) was increased in rats after BPNI ( d ) and SCI ( e ). Scale bar = 400 μm. Protein levels of fibroblasts differentiation-related markers (α-SMA and Col-1) in BFs isolated from rats treated with BPNI ( f ) and SCI ( g ). Representative western blotting showing the phenotypic transformation of SMCs (SMTN and MYH10) in BPNI ( h ) and SCI ( i ) rats. Western blotting analyses showing protein levels of WNT11 and markers of fibroblastic differentiation (α-SMA and Col-1) and SMCs phenotypic transformation (SMTN and MYH10) in BFs ( j ) and SMCs ( k ) treated with TGF-β1 at different doses, respectively. Data are shown as the mean ± SD, and P values were determined by the one-way ANOVA followed by Tukey’s post-hoc test ( a ), * P < 0.05, ** P < 0.01.

    Journal: Communications Biology

    Article Title: Wnt11 mediates fibroblast–smooth muscle cell interaction to promote neurogenic bladder fibrosis in rats

    doi: 10.1038/s42003-026-09647-2

    Figure Lengend Snippet: a Relative mRNA level of WNT11 in fibrotic bladders following BPNI and SCI ( n = 8). Western blotting of WNT11 expression in BPNI ( b ) and SCI ( c )-induced NB. Representative photomicrographs showed that WNT11 (green) was increased in rats after BPNI ( d ) and SCI ( e ). Scale bar = 400 μm. Protein levels of fibroblasts differentiation-related markers (α-SMA and Col-1) in BFs isolated from rats treated with BPNI ( f ) and SCI ( g ). Representative western blotting showing the phenotypic transformation of SMCs (SMTN and MYH10) in BPNI ( h ) and SCI ( i ) rats. Western blotting analyses showing protein levels of WNT11 and markers of fibroblastic differentiation (α-SMA and Col-1) and SMCs phenotypic transformation (SMTN and MYH10) in BFs ( j ) and SMCs ( k ) treated with TGF-β1 at different doses, respectively. Data are shown as the mean ± SD, and P values were determined by the one-way ANOVA followed by Tukey’s post-hoc test ( a ), * P < 0.05, ** P < 0.01.

    Article Snippet: To maximally activate or inhibit the WNT cascade in vivo, rats were treated with recombinant WNT11 protein (#6179-WN-010, R&D Systems) or LGK974 (#HY-17545, MedChemExpress) immediately after the surgical procedure.

    Techniques: Western Blot, Expressing, Isolation, Transformation Assay

    a – n Eight-week-old male Sprague–Dawley rats were subjected to sham, BPNI, or SCI operation. Vehicle, WNT11, or LGK974 were administered to rats every day after the surgical procedure for 2 weeks, and these rats were euthanized at post 4 weeks of operation. a Schematic of the experimental protocol and treatment regimen. b Representative bladder images in rats treated with vehicle, WNT11, or LGK974 post BPNI or SCI. Representative images of cystometrograms in rats after BPNI ( c ) or SCI ( d ). Statistical results for the intravesical pressure in rats after BPNI ( e ) or SCI ( f ) ( n = 5). Histological analysis of the Masson’s trichrome staining in bladders after BPNI ( g ) or SCI ( h ). Scale bar = 200 μm. Quantifications of detrusor thickness ( i , j ) and collagen content ( k , l ) by Masson’s trichrome staining were performed to assess the bladder fibrosis ( n = 5). Western blotting showing the protein levels of WNT11 and markers of fibroblastic differentiation (α-SMA and Col-1) and SMCs phenotypic transformation (SMTN and MYH10) in bladders after BPNI ( m ) or SCI ( n ). Western blotting analyses showing protein levels of TGF-β1 and markers of fibroblastic differentiation (α-SMA and Col-1) and SMCs phenotypic transformation (SMTN and MYH10) in BFs ( o ) and SMCs ( p ) treated with WNT11 at different doses. Western blotting analyses showing siWNT11 transfection inhibiting fibroblastic differentiation and SMCs phenotypic transformation in BFs ( q ) and SMCs ( r ) with TGF-β1 treatment, respectively. Data are shown as the mean ± SD, and P values were determined by the two-way ANOVA followed by Tukey’s post-hoc test ( e , f , i – l ), ns = not significant, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

    Journal: Communications Biology

    Article Title: Wnt11 mediates fibroblast–smooth muscle cell interaction to promote neurogenic bladder fibrosis in rats

    doi: 10.1038/s42003-026-09647-2

    Figure Lengend Snippet: a – n Eight-week-old male Sprague–Dawley rats were subjected to sham, BPNI, or SCI operation. Vehicle, WNT11, or LGK974 were administered to rats every day after the surgical procedure for 2 weeks, and these rats were euthanized at post 4 weeks of operation. a Schematic of the experimental protocol and treatment regimen. b Representative bladder images in rats treated with vehicle, WNT11, or LGK974 post BPNI or SCI. Representative images of cystometrograms in rats after BPNI ( c ) or SCI ( d ). Statistical results for the intravesical pressure in rats after BPNI ( e ) or SCI ( f ) ( n = 5). Histological analysis of the Masson’s trichrome staining in bladders after BPNI ( g ) or SCI ( h ). Scale bar = 200 μm. Quantifications of detrusor thickness ( i , j ) and collagen content ( k , l ) by Masson’s trichrome staining were performed to assess the bladder fibrosis ( n = 5). Western blotting showing the protein levels of WNT11 and markers of fibroblastic differentiation (α-SMA and Col-1) and SMCs phenotypic transformation (SMTN and MYH10) in bladders after BPNI ( m ) or SCI ( n ). Western blotting analyses showing protein levels of TGF-β1 and markers of fibroblastic differentiation (α-SMA and Col-1) and SMCs phenotypic transformation (SMTN and MYH10) in BFs ( o ) and SMCs ( p ) treated with WNT11 at different doses. Western blotting analyses showing siWNT11 transfection inhibiting fibroblastic differentiation and SMCs phenotypic transformation in BFs ( q ) and SMCs ( r ) with TGF-β1 treatment, respectively. Data are shown as the mean ± SD, and P values were determined by the two-way ANOVA followed by Tukey’s post-hoc test ( e , f , i – l ), ns = not significant, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

    Article Snippet: To maximally activate or inhibit the WNT cascade in vivo, rats were treated with recombinant WNT11 protein (#6179-WN-010, R&D Systems) or LGK974 (#HY-17545, MedChemExpress) immediately after the surgical procedure.

    Techniques: Staining, Western Blot, Transformation Assay, Transfection

    Representative western blotting and quantitative analyses for FZD10 and Vangl2 in bladders after BPNI ( a ) or SCI ( b ) ( n = 6). Interaction between endogenous WNT11 and Vangl2 in BFs ( c ) and SMCs ( d ). e Confocal microscopy analysis of BFs and SMCs showing the colocalization of WNT11 (red) and Vangl2 (green). Scale bar = 20 μm. Quantification of colocalization was ascertained by ImageJ software in five randomly chosen fields. Numbers in the images correspond to the average Pearson’s correlation coefficient ± SD. Representative Western blotting and summarized data showing the relative protein levels of Vangl2 and markers of fibroblastic differentiation (α-SMA and Col-1) and SMCs phenotypic transformation (SMTN and MYH10) in BFs ( f ) and SMCs ( g ) ( n = 4). Data are shown as the mean ± SD. P values were determined by the two-tailed unpaired Student’s t -test ( a , b ) and the two-way ANOVA followed by Tukey’s post-hoc test ( f , g ), * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

    Journal: Communications Biology

    Article Title: Wnt11 mediates fibroblast–smooth muscle cell interaction to promote neurogenic bladder fibrosis in rats

    doi: 10.1038/s42003-026-09647-2

    Figure Lengend Snippet: Representative western blotting and quantitative analyses for FZD10 and Vangl2 in bladders after BPNI ( a ) or SCI ( b ) ( n = 6). Interaction between endogenous WNT11 and Vangl2 in BFs ( c ) and SMCs ( d ). e Confocal microscopy analysis of BFs and SMCs showing the colocalization of WNT11 (red) and Vangl2 (green). Scale bar = 20 μm. Quantification of colocalization was ascertained by ImageJ software in five randomly chosen fields. Numbers in the images correspond to the average Pearson’s correlation coefficient ± SD. Representative Western blotting and summarized data showing the relative protein levels of Vangl2 and markers of fibroblastic differentiation (α-SMA and Col-1) and SMCs phenotypic transformation (SMTN and MYH10) in BFs ( f ) and SMCs ( g ) ( n = 4). Data are shown as the mean ± SD. P values were determined by the two-tailed unpaired Student’s t -test ( a , b ) and the two-way ANOVA followed by Tukey’s post-hoc test ( f , g ), * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

    Article Snippet: To maximally activate or inhibit the WNT cascade in vivo, rats were treated with recombinant WNT11 protein (#6179-WN-010, R&D Systems) or LGK974 (#HY-17545, MedChemExpress) immediately after the surgical procedure.

    Techniques: Western Blot, Confocal Microscopy, Software, Transformation Assay, Two Tailed Test

    Representative western blotting and quantitative analyses for the phosphorylation levels of JNK and c-JUN in bladders after BPNI ( a ) or SCI ( b ) ( n = 3). BFs ( c ) and SMCs ( d ) developed higher expression levels of p-JNK and p-c-JUN upon WNT11 treatment as indicated by the western blotting and quantitative analyses ( n = 4). Representative immunofluorescence staining and quantitative analyses showing that WNT11 treatment increased the fluorescence intensity and accumulation of p-c-JUN in the nucleus of BFs ( e ) and SMCs ( f ) ( n = 4). Scale bar=100μm. Protein levels of p-JNK, p-c-JUN, and markers of fibroblastic differentiation (α-SMA and Col-1) and SMCs phenotypic transformation (SMTN and MYH10) in BFs ( g ) and SMCs ( h ) treated with WNT11 with or without SP600125 by western blotting ( n = 3). Data are shown as the mean ± SD. P values were determined by the two-way ANOVA followed by Tukey’s post-hoc test ( a , b , g , h ) and the two-tailed unpaired student’s t -test ( c – f ), * P < 0.05, ** P < 0.01, *** P < 0.001.

    Journal: Communications Biology

    Article Title: Wnt11 mediates fibroblast–smooth muscle cell interaction to promote neurogenic bladder fibrosis in rats

    doi: 10.1038/s42003-026-09647-2

    Figure Lengend Snippet: Representative western blotting and quantitative analyses for the phosphorylation levels of JNK and c-JUN in bladders after BPNI ( a ) or SCI ( b ) ( n = 3). BFs ( c ) and SMCs ( d ) developed higher expression levels of p-JNK and p-c-JUN upon WNT11 treatment as indicated by the western blotting and quantitative analyses ( n = 4). Representative immunofluorescence staining and quantitative analyses showing that WNT11 treatment increased the fluorescence intensity and accumulation of p-c-JUN in the nucleus of BFs ( e ) and SMCs ( f ) ( n = 4). Scale bar=100μm. Protein levels of p-JNK, p-c-JUN, and markers of fibroblastic differentiation (α-SMA and Col-1) and SMCs phenotypic transformation (SMTN and MYH10) in BFs ( g ) and SMCs ( h ) treated with WNT11 with or without SP600125 by western blotting ( n = 3). Data are shown as the mean ± SD. P values were determined by the two-way ANOVA followed by Tukey’s post-hoc test ( a , b , g , h ) and the two-tailed unpaired student’s t -test ( c – f ), * P < 0.05, ** P < 0.01, *** P < 0.001.

    Article Snippet: To maximally activate or inhibit the WNT cascade in vivo, rats were treated with recombinant WNT11 protein (#6179-WN-010, R&D Systems) or LGK974 (#HY-17545, MedChemExpress) immediately after the surgical procedure.

    Techniques: Western Blot, Phospho-proteomics, Expressing, Immunofluorescence, Staining, Fluorescence, Transformation Assay, Two Tailed Test

    Relative mRNA levels of DVL1, DVL2, and DVL3 in fibrotic bladders at 4 weeks after BPNI ( a ) and SCI ( b ) ( n = 6). Representative western blotting and quantitative analyses for the protein levels of DVL1, DVL2, and DVL3 in bladders after BPNI ( c ) or SCI ( d ) ( n = 6). e Representative western blotting and quantitative analyses revealing the protein levels of DVL2 and markers of fibroblastic differentiation, and the phosphorylation levels of JNK and c-JUN in BFs ( n = 3). f Protein levels of p-c-JUN, p-JNK, DVL2, SMTN, and MYH10 in SMCs treated with WNT11 and/or siDVL2 ( n = 3). Immunoprecipitation demonstrated that DVL2 bound to Vangl2 in BFs ( g ) and SMCs ( h ). Representative western blotting showing the presence of the target proteins (input) and immunoprecipitation showing the interaction of Flag-DVL2, Flag-DEP, Flag-DIX, and Flag-PDZ with endogenous Vangl2 in HEK293T cells using antibodies to Flag ( i ) and IgG ( j ). Data are shown as the mean ± SD. P values were determined by the two-tailed unpaired Student’s t -test ( a – d ) and the two-way ANOVA followed by Tukey’s post-hoc test ( e , f ), * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

    Journal: Communications Biology

    Article Title: Wnt11 mediates fibroblast–smooth muscle cell interaction to promote neurogenic bladder fibrosis in rats

    doi: 10.1038/s42003-026-09647-2

    Figure Lengend Snippet: Relative mRNA levels of DVL1, DVL2, and DVL3 in fibrotic bladders at 4 weeks after BPNI ( a ) and SCI ( b ) ( n = 6). Representative western blotting and quantitative analyses for the protein levels of DVL1, DVL2, and DVL3 in bladders after BPNI ( c ) or SCI ( d ) ( n = 6). e Representative western blotting and quantitative analyses revealing the protein levels of DVL2 and markers of fibroblastic differentiation, and the phosphorylation levels of JNK and c-JUN in BFs ( n = 3). f Protein levels of p-c-JUN, p-JNK, DVL2, SMTN, and MYH10 in SMCs treated with WNT11 and/or siDVL2 ( n = 3). Immunoprecipitation demonstrated that DVL2 bound to Vangl2 in BFs ( g ) and SMCs ( h ). Representative western blotting showing the presence of the target proteins (input) and immunoprecipitation showing the interaction of Flag-DVL2, Flag-DEP, Flag-DIX, and Flag-PDZ with endogenous Vangl2 in HEK293T cells using antibodies to Flag ( i ) and IgG ( j ). Data are shown as the mean ± SD. P values were determined by the two-tailed unpaired Student’s t -test ( a – d ) and the two-way ANOVA followed by Tukey’s post-hoc test ( e , f ), * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

    Article Snippet: To maximally activate or inhibit the WNT cascade in vivo, rats were treated with recombinant WNT11 protein (#6179-WN-010, R&D Systems) or LGK974 (#HY-17545, MedChemExpress) immediately after the surgical procedure.

    Techniques: Western Blot, Phospho-proteomics, Immunoprecipitation, Two Tailed Test

    Under the condition of bladder denervation, the WNT11/Vangl2 signal was transmitted into the cytoplasm via DVL2, followed by activating PCP signaling to promote fibroblastic differentiation and SMC phenotypic transformation, which also depended on the interaction of TGF-β1/Smad2/3 signaling at the level of cytomembrane and nucleus, eventually resulting in NB fibrosis.

    Journal: Communications Biology

    Article Title: Wnt11 mediates fibroblast–smooth muscle cell interaction to promote neurogenic bladder fibrosis in rats

    doi: 10.1038/s42003-026-09647-2

    Figure Lengend Snippet: Under the condition of bladder denervation, the WNT11/Vangl2 signal was transmitted into the cytoplasm via DVL2, followed by activating PCP signaling to promote fibroblastic differentiation and SMC phenotypic transformation, which also depended on the interaction of TGF-β1/Smad2/3 signaling at the level of cytomembrane and nucleus, eventually resulting in NB fibrosis.

    Article Snippet: To maximally activate or inhibit the WNT cascade in vivo, rats were treated with recombinant WNT11 protein (#6179-WN-010, R&D Systems) or LGK974 (#HY-17545, MedChemExpress) immediately after the surgical procedure.

    Techniques: Transformation Assay

    Isolation, characterization and differentiation of chicken enteric neurospheres. Schematic figure of avian enteric neurosphere generation (A) . Brightfield images show examples of neurospheres generated from E8 ENSCs that emerged 1, 3, and 7 days in GDNF-containing medium (B–D) . Representative immunofluorescence images of 7-day-old neurospheres generated from E8 chicken intestine (E–G) . Samples were cultured under three different conditions: Exp.1: control medium ( (E) , CTRL), Exp. 2: GDNF containing cell culture media ( (F) , GDNF), and Exp.3: GWEN ( (G) , ceca-derived mesenchymal growth factors: GDNF, WNT11, ET-3, Noggin) supplemented media. Immunofluorescence of cross-sections confirms the presence of neurons expressing TUJ1, and neural crest cells expressing PHOX2B. Compared to CTRL and GDNF-only conditions, GWEN treatment resulted in a robust increase in TUJ1+/PHOX2B+ cell aggregates on the surface of the neurosphere and single Phox2b+ cells in the center of the aggregates. The inset shows a magnified view of a PHOX2B+/TUJ1+ aggregate, indicating enhanced differentiation of neural crest derivatives (E–G) . Scale bar = 100 µm. CTRL, control; NS, neurosphere.

    Journal: Frontiers in Cell and Developmental Biology

    Article Title: Cecal growth factors promote enteric neurosphere formation and hindgut colonization in the avian model

    doi: 10.3389/fcell.2025.1681844

    Figure Lengend Snippet: Isolation, characterization and differentiation of chicken enteric neurospheres. Schematic figure of avian enteric neurosphere generation (A) . Brightfield images show examples of neurospheres generated from E8 ENSCs that emerged 1, 3, and 7 days in GDNF-containing medium (B–D) . Representative immunofluorescence images of 7-day-old neurospheres generated from E8 chicken intestine (E–G) . Samples were cultured under three different conditions: Exp.1: control medium ( (E) , CTRL), Exp. 2: GDNF containing cell culture media ( (F) , GDNF), and Exp.3: GWEN ( (G) , ceca-derived mesenchymal growth factors: GDNF, WNT11, ET-3, Noggin) supplemented media. Immunofluorescence of cross-sections confirms the presence of neurons expressing TUJ1, and neural crest cells expressing PHOX2B. Compared to CTRL and GDNF-only conditions, GWEN treatment resulted in a robust increase in TUJ1+/PHOX2B+ cell aggregates on the surface of the neurosphere and single Phox2b+ cells in the center of the aggregates. The inset shows a magnified view of a PHOX2B+/TUJ1+ aggregate, indicating enhanced differentiation of neural crest derivatives (E–G) . Scale bar = 100 µm. CTRL, control; NS, neurosphere.

    Article Snippet: To assess the effect of ceca-specific mesenchymal factors on enteric neural stem cells, the culture medium was further supplemented with 10 ng/mL glial cell line-derived neurotrophic factor (GDNF; R&D Systems, 212-GD-010), 200 ng/mL WNT11 (Origene, TP761904), 250 ng/mL endothelin-3 (ET-3; R&D Systems, 1,162/100U), and 100 ng/mL Noggin (R&D Systems, 6997-NG-025).

    Techniques: Isolation, Generated, Immunofluorescence, Cell Culture, Control, Derivative Assay, Expressing